Ashish Nimgaonkar
Company: Gylscend
Job title: Chief Medical Officer
Seminars:
Reshaping the Treatment of Metabolic Diseases via Gut Mediated Mechanisms 2:20 pm
Learnings from bariatric surgery on gut-mediated physiological metabolic regulation GLY-200 program: a first-in-class oral drug that mimics the pleiotropic effects of bariatric surgery Leveraging gut mechanisms to amplify GLP1RA effectsRead more
day: Conf Day 1 Track 1 PM